Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-09-27 to 2022-10-19
Current total value of award: $4534.08
Description: 4558631503!OMIDRIA 1-0.3% VIAL 4ML